PuraMed BioScience completes clinical study of LipiGesic M for treating acute migraine
PuraMed BioScience, announced today that a clinical study of LipiGesic M has been completed. The study design was a double blind, placebo controlled, multi-site study measuring the effectiveness of LipiGesic’
Leave a Response
You must be logged in to post a comment.
